alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › fad-mice

fad-mice

2 studies tagged fad-mice, dated 2022-12-27 to 2025-04-04. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. A novel dual CCK/ GLP-1 receptor agonist ameliorates cognitive impairment in 5 × FAD mice by modulating mitophagy via the PINK1/Parkin pathway 2025-04-04
  2. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model 2022-12-27

Studies

2 studies carry this tag.

Date range

2022 to 2025

Top journals

  • International immunopharmacology 1
  • Translational neurodegeneration 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A novel dual CCK/ GLP-1 receptor agonist ameliorates cognitive impairment in 5 × FAD mice by modulating mitophagy via the PINK1/Parkin pathway

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. International immunopharmacology 2025-04-04 Drug development

    To date, no therapeutic drugs available on the market can effectively reverse the progression of Alzheimer's disease (AD).

  2. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Translational neurodegeneration 2022-12-27 Treatments

    The enhanced delivery of a low dose of Adu (3 mg/kg) via FUS decreases amyloid deposits and attenuates cognitive function deficits.

All topic tags with their study counts